US EditionQihan Biotech Presented its Breakthrough CAR-T Research at ASGCT 2025
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Qihan Biotech Presented its Breakthrough CAR-T Research at ASGCT 2025
HANGZHOU, China–(BUSINESS WIRE)–Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced new advancements in its universal CAR-T cell therapy research, to be presented at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT). Through systematic exploration of T cell cytokine…
CAR-T therapy is a form of cellular immunotherapy in which the patient's own T lymphocytes are extracted to genetically modify them and provide them with chimeric antigen receptors (CARs), capable of recognizing and destroying tumor cells. The process includes the removal of blood, genetic engineering of the cells in the laboratory and their re-infusion into the patient, where they multiply and fight cancer in a targeted way. It is a very comple…
Compostela could only provide treatment to the paediatric population until now, while Corunia was the only one directed to older people The article Vigo and Santiago Hospitals will administer CAR-T therapy to adult patients first published in GCencia.
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
This year’s American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, held May 13–17 in New Orleans, is buzzing with new breakthroughs from the … Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More Read More » The post Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More first appeared on GeneOnline News. The post Gene and Cell Therapie…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
